Invus
Fund Type
Venture Fund
Founding Year
1985
About
Invus recognizes that every company is unique and that extraordinary business performance cannot be achieved by following a formulaic
Stages
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Investments
163
Geography
New York
Exits
49
Sectors
BioTechPharmaceuticalsHealthcareMedical DeviceWearables & Quantified SelfArtificial Intelligence & Machine Learning (AI/ML)FinTechFood and BeverageHospitalityRestaurantTechLife Science
Portfolio Companies
KSQ TherapeuticsElement ScienceEngine BiosciencesImvaxLocanabioAbata TherapeuticsMarlette FundingCava GroupLarondeRing TherapeuticsRepertoire Immune MedicinesLyndra Therapeutics